Domestic Surge Masks Profit Quality Decay
Revenue growth of 19% YoY looks solid on the surface, but EBITDA margins compressed 80 basis points and PAT grew only 11% — cost recovery is just 30–40% complete, leaving profit hostage to customer negotiations.
18.8%
YoY; matches guidance
10.6%
YoY; lags revenue growth
9.2%
vs 10.0% prior year; −80 bps compression
30–40%
Remaining 60–70% under negotiation
Carraro delivered revenue within guidance — ₹696.5 crore, +19% YoY — and domestic growth is genuinely strong at 30% in H1. But the quarter's real story is a profit-quality miss. PAT grew only 11%, less than half the revenue growth rate. EBITDA margins compressed 80 basis points to 9.2% despite 19% revenue growth, and gross margin fell a sharp 310 basis points to 23.3%. The culprit is unmistakable: cost inflation (steel, castings, freight, labor) has been recovered at only 30–40% across the customer base, leaving the remaining 60–70% still under negotiation. Management calls it 'anybody's guess' when the gap closes.
The cost recovery hostage situation
Carraro's contract structure with tractor and construction OEMs is typically indexed to commodity costs, but with a 3–6 month lag. In Q2, raw material inflation drove up input costs sharply. Management negotiated recovery with some customers — enough to offset about one-third of the increase — but the majority of the gap remains in discussion. On the call, negotiations were described as 'constructive,' but no timeline or recovery guarantee was offered. This is the crux: gross margin cannot recover until these negotiations close. If they stall or customers push back citing their own demand softness, EBITDA could remain 50–100 basis points below the prior 10% level for several quarters.
What held up vs. what slipped
Q2 revenue 19% YoY, 28% sequential; H1 domestic grew 30%
Q2 revenue 18.8% YoY, 27.9% QoQ; H1 domestic ₹8,654 Cr vs ₹6,654 Cr prior (30% confirmed)
Supported
H1 EBITDA up 8%; PAT margin 5.3%
H1 EBITDA growth 8% fits trajectory; Q2 PAT margin 5.0%, H1 estimated 5.3%
Supported
Cost price increases recovered 30–40%; remaining gap under negotiation
EBITDA margin fell 80 bps YoY despite volume growth; only partial recovery achieved
Supported but incomplete
Localization improved to 80% in Q2 from 74% in Q1; target 86–88%
Localization recovery confirmed; target remains 86–88%, 6–8 ppts away
Supported
4-wheel drive penetration toward 35–40% range over coming years; Carraro at ~25%
Carraro ~25% market share, targeting 27–28% near-term; 35–40% is multi-year target
Slightly overstated (35–40% not imminent)
What changed on this call
Domestic strength — 30% H1 growth in agriculture; 4-wheel penetration rising toward 27–28% from 25%
Localization recovering — improved to 80% from 74%, though still 6–8 ppts below target
TBH axle on track — year 2 of 3-year ₹300 Cr ramp, now at ₹180–200 Cr run-rate (~60% of goal)
Margin recovery hedged — cost recovery only 30–40% done; remaining 60–70% 'anybody's guess' on timeline
Export outlook softened — expected 'flatish, plus slightly up' for full year; H1 down 8% YoY
Engineering services deprioritized — described as 'mid-course correction'; no longer a standalone revenue target
The bull-bear ledger
Domestic (70% of revenue) growing 30% YoY; structural shift from 2-wheel to 4-wheel tractors intact
4-wheel drive penetration runway to 35–40% over multi-year horizon provides multi-year visibility
TBH axle export program gaining traction; ₹300 Cr in 3-year target on track, now ~60% achieved
Localization improving (74% → 80%); supply chain normalization visible; path to 86–88% target exists
New capacity (paint shop, backlash machine, 4-wheel axle line) commissioned; utilization leverage ahead
Zero customer revenue loss in 30 years; OEM relationships durable; pricing power negotiable, not lost
Margin compression (−80 bps EBITDA) amid 19% revenue growth signals weak pricing power against inflation
Cost recovery only 30–40% done; remaining 60–70% hostage to customer negotiations, no firm timeline
Gross margin fell 310 bps (26.4% → 23.3%); recovery uncertain and timing dependent on negotiation completion
Export revenue down 8% YoY H1; management expects 'flatish' recovery; West Asia geopolitical risk ongoing
PAT growth (10.6%) significantly lags revenue growth (18.8%); operating leverage not translating to bottom-line
OEM capacity constraints capping 4-wheel growth near-term; Carraro dependent on OEM demand scaling
Risks, ranked by holder concern
Cost recovery negotiations fail or stall beyond H2 FY27
HighEBITDA margin could remain 50–100 bps below 10% level. PAT growth would stall despite revenue growth, validating profit-quality concerns and triggering institutional exit acceleration.
Export market remains weak; West Asia geopolitical disruption escalates
MediumExports ~30% of revenue; H1 down 8% YoY. If weakness persists, FY27 full-year 10–15% growth guidance could miss, despite domestic strength offsetting only part of export gap.
OEM capacity constraints cap 4-wheel penetration growth near-term
MediumCarraro's 25% market share dependent on OEM demand. If OEMs don't scale production due to demand softness, Carraro's penetration upside stalls and long-term ₹3,500–4,000 Cr FY30 target at risk.
Commodity price reset lower; prior-quarter recoveries become negotiation reversals
MediumIf steel/casting prices fall sharply, customers leverage index clauses to push for price cuts. Indexed contracts protect upside but amplify downside in commodity crash scenarios.
Localization target (86–88%) not achieved; supply disruption resumes
LowCurrently 80%; if supply normalizes slower than expected, margin leverage from cost reduction is delayed, pushing margin recovery into FY28.
How the street is positioned — and what it's telling us
The market is confirming the profit-quality concern. Carraro's stock is trading at ₹482, down 30.39% from its all-time high of ₹692.4, and well below all key moving averages (SMA20 ₹488.5, SMA50 ₹511.74, SMA200 ₹526.98). The RSI of 43.2 is neutral-to-weak, reflecting absence of conviction. More tellingly: FII ownership collapsed from 2.91% in Q1 to 1.59% in Q2 (−132 basis points), and DII also trimmed (−80 bps). Institutions are exiting into strength — a classic sell signal for a stock facing margin pressure and unresolved cost recovery. Volume is normal, so it's not illiquidity; it's fundamental repositioning. The 30% drawdown from ATH is steep, but the Q2 result (margin compression, cost recovery incomplete, PAT growth lagging revenue) justifies institutional caution. Until cost recovery closes or gross margin stabilizes toward 24.5%+, expect further FII trimming.
The debate
What to watch next
1 · H2 / Q3 cost recovery announcement
Management says remaining 60–70% is under negotiation. Any Q3 guidance raise or confirmed recovery % would signal negotiations are closing. Target: EBITDA margin back to 9.8%+ and gross margin stabilization toward 24.5%+, implying 50%+ cumulative cost recovery achieved.
2 · Localization trajectory
Current 80% vs. target 86–88%; each 1 ppt closer to target implies ~10–15 bps EBITDA margin lift from cost reduction. Track quarterly progress. If Q3 shows >81%, recovery is on pace. If stuck at 80%, supply disruption narrative strengthens.
3 · Export stabilization and Q3 volume
H1 down 8% YoY; Q2 showed recovery vs Q1 (+27%). If Q3 continues momentum (>5–10% QoQ growth vs Q2), export narrative shifts from headwind to stabilizing. This would help reach FY27 full-year 10–15% growth guidance.
4 · TBH axle ramp and new OEM orders
Currently ₹180–200 Cr run-rate (55–60% of 3-year ₹300 Cr goal). Any new global OEM order or production ramp-up update validates the ₹300 Cr pathway and de-risks FY28 growth guidance of ~10% (implied by ₹2,500 Cr target).
Carraro's Q2 is a case study in growth masking profitability headwinds. Revenue growth is real and will likely meet guidance; domestic demand is structural. But PAT grew only half as fast as revenue, margins compressed, and cost recovery remains incomplete. This is not a story resolved in one quarter. The bull case exists (domestic tailwinds, TBH ramp, long-term runway to 35–40% penetration), but it's hostage to near-term margin recovery. Until gross margin stabilizes (target: 24.5%+) and EBITDA recovers to 9.8%+, the stock faces continued headwinds. H2/Q3 will be decisive — that's when customer negotiations should yield visible progress and de-risk the margin narrative. For now: hold, watch closely for cost recovery signs, and track gross margin as the north star.
Informational and educational content only. Not investment advice.